Corillian ( CORI) rocketed more than 45% after the company, which sells Internet-based software to financial services firms, agreed to sell itself to electronic payment processor CheckFree ( CKFR) for $5.15 a share, or roughly $245 million. The deal will likely close around June 1. Oregon-based Corillian was rising $1.57 to $5.02. Checkfree shares were dipping 42 cents, or 1%, to $41.20.

Cumberland Resources ( CLG) shot up 23.3% on word fellow Canadian gold miner Agnico-Eagle Mines ( AEM) will buy it in a stock swap that values Cumberland around $608.9 million. Cumberland was up $1.38 to $7.33. Agnico-Eagle was losing 84 cents, or 2%, to $40.38.

SPSS ( SPSS) jumped after the analytical-software company said fourth-quarter operating income spiked 36% to $11.7 million from a year ago; excluding a large noncash income tax charge, per-share earnings totaled 43 cents. Revenue rose 14% year over year to $71.1 million. Analysts polled by Thomson Financial were looking for 34 cents a share on revenue of $67.5 million. Shares of the Chicago-based company were up $4.91, or 15.4%, to $36.79.

San Diego, Calif., biotech Halozyme Therapeutics ( HTI) announced an expansion of its existing Hylenax-recombinant agreement with medical-products maker Baxter ( BAX). The deal now allows Baxter to use Hylenax with its small-molecule drugs, for which the former will pay Halozyme $10 million upfront and buy $20 million worth of Halozyme equity, in addition to possible milestone payments and royalties. Halozyme shares were gaining $1, or 12.7%, to $8.85. Baxter was edging up 17 cents to $50.11.

PF Chang's China Bistro ( PFCB) rose after the Scottsdale, Ariz.-based restaurateur posted fourth-quarter income of $8.8 million, or 34 cents a share, easily beating the 26-cent per-share consensus. Earnings were essentially flat with last year. Revenue climbed to $252 million from $213.8 million a year ago, squeaking past the $251.2 million mean target. Shares were up $3.02, or 7.5%, to $43.21.

Advancis Pharma ( AVNC) shares fell sharply on news that the Food and Drug Administration rejected a new drug application for the Maryland-based company's proposed strep throat treatment, Amoxicillin Pulsys, citing inadequate information on the commercial manufacturing plans. Chief Executive Edward Rudnic says Advancis will be able to address these concerns "relatively quickly" for resubmission. Shares were losing 66 cents, or 24%, to $2.09.

Baby-apparel maker Carter's ( CRI) was sliding on disappointing 2007 guidance. The Atlanta-company pegged full-year profits between $1.42 and $1.49 a share on sales of $1.4 billion to $1.42 billion, and expects no same-store sales growth. Wall Street is seeking earnings of $1.72 a share on sales of $1.47 billion.

Preliminary fourth-quarter results were in line with estimates, with per-share earnings of 46 cents, excluding acquisition-related amortization, on sales of $377.5 million. However, shares were sinking $3.46, or 13.7%, to $21.81.

Electronic-components maker Wells-Gardner ( WGA) posted lower-than-expected fourth-quarter results. Earnings came to $247,000, or 3 cents a share, up from a loss of $679,000, or 8 cents a share, a year ago. Analysts were seeking a nickel a share in earnings. Sales rose 18.8% to $15.9 million, just short of the $16.4 million estimates. Shares were lower by 53 cents, or 11.9%, to $3.91.

Vion Pharma ( VION) tumbled on word it will sell up to $60 million in convertible senior notes as well as warrants for purchase of up to 7.8 million company shares. The New Haven, Conn., biotech was off 15 cents, or 9.4%, to $1.45.

Gulf Island Fabrication ( GIFI) delayed the release of its year-end 2006 financials, which was originally slated for Feb. 13 after market close. The Houma, La.-based company, which makes structures for oil and gas drilling, expects to file on or before the March 16 regulatory deadline. Shares were down $3.11, or 8.2%, to $34.88.

1-800-Flowers ( FLWS) shares dropped after a Goldman Sachs analyst said the flower purveyor is overvalued, and cut the stock's rating to a sell. Shares were declining 60 cents, or 8%, to $6.91.

More from Investing

Tesla CEO Elon Musk Is a Rock Star: Kiss Icon Gene Simmons

Tesla CEO Elon Musk Is a Rock Star: Kiss Icon Gene Simmons

Macy's Vs. J.C. Penney: Which Department Store Is Just Trying to Survive?

Macy's Vs. J.C. Penney: Which Department Store Is Just Trying to Survive?

The Best Investment Advice? Stay Diversified

The Best Investment Advice? Stay Diversified

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

After PayPal Buys iZettle, Pay-Tech Firms Could Process These Deals

After PayPal Buys iZettle, Pay-Tech Firms Could Process These Deals